September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Increased Connexin43 expression in a mouse model of advanced diabetic retinopathy
Author Affiliations & Notes
  • Odunayo Omolola Rotimi
    Ophthalmology, The University of Auckland, Auckland, New Zealand
  • Colin Green
    Ophthalmology, The University of Auckland, Auckland, New Zealand
  • Jie Zhang
    Ophthalmology, The University of Auckland, Auckland, New Zealand
  • Monica L Acosta
    Optometry and Vision Science, The University of Auckland, Auckland, New Zealand
  • Ilva Rupenthal
    Ophthalmology, The University of Auckland, Auckland, New Zealand
  • Footnotes
    Commercial Relationships   Odunayo Rotimi, None; Colin Green, CoDa Therapeutics Inc. (P); Jie Zhang, None; Monica Acosta, None; Ilva Rupenthal, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5430. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Odunayo Omolola Rotimi, Colin Green, Jie Zhang, Monica L Acosta, Ilva Rupenthal; Increased Connexin43 expression in a mouse model of advanced diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5430.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Diabetic retinopathy is a complication of diabetes that leads to vision loss in over 50% of diabetic patients. A novel transgenic mouse with enhanced expression of vascular endothelial growth factor (VEGF) and insulin deficiency (Akimba, Ins-/- VEGF+/-) has shown unique features of advanced diabetic retinopathy. Since other vascular disorders such as those resulting from spinal cord injury and retinal ischemia have shown increased Connexin43 levels and hemichannel opening, we hypothesize that the progression of vascular changes in Akimba mice is also associated with higher Connexin43 expression.

Methods : Retinal sections from 24 week old male Akimba and age-matched control (C57BL/6) mice (n=4) were immunohistochemically labelled for Connexin43 protein, astrocytosis and neovascularization using antibodies against Connexin43, glial fibrillary acidic protein (GFAP) and plasmalemma vesicular associated protein (PLVAP) in conjunction with the nuclear stain DAPI.

Results : GFAP labelling was restricted to the ganglion cell layer in control mice but extended into all retinal layers in Akimba mice indicating Müller cell activation. There was a significant increase in both astrocytosis (p = 0.001) and overall Connexin43 levels (p = 0.002) as well as an upregulation of Connexin43 clusters on endothelial cells of new blood vessels in Akimba mice (p < 0.0001).

Conclusions : Astrocytosis and neovascularization correlated with increased Connexin43 expression in new blood vessels in the Akimba diabetic retinopathy model. These findings support a causal role of Connexin43 channels in the disease progression. Therefore, blocking Connexin43 hemichannels may be a novel therapeutic option to reduce vascular disruption in diabetic retinopathy.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×